叮噹健康(09886.HK)曾逆市飆1.9倍創上市高 平安好醫生(01833.HK)績後升4%
港股今早(14日)曾挫逾500點或2.6%,低見19,193,現報19,358,跌337點或1.7%,成交近675億元。惟內地數字醫療健康到家服務提供商叮噹健康(09886.HK)今早一度逆市飆1.9倍,盤中高見20.2元創上市高,隨後升幅顯著收窄,現報10.8元,升55.6%,成交432.7萬股,涉資5,385.74萬元。
公司日前(12日)公布,控股股東集團作出第二次禁售承諾,將首個禁售期由今年3月13日延長至9月13日。涉及股份共計6.6億股,佔公司總股本49.21%。
去年9月上市的叮噹健康本月上旬發盈警,預計2022年止年度淨虧損將較2021年度的15.99億人民幣增加不少於83%。主要是年內具有優先股權的股份按公平值計的金融負債損失增加;撇除相關損失以及以股份為基礎的付款及上市開支,全年經調整淨虧損將較2021年度的3.3億人民幣收窄不少於50%。
另外,去年虧損收窄的平安好醫生(01833.HK)盤中曾微跌0.5%後反覆轉升,現報18.5元,升4.1%,成交832.83萬股,涉資1.55億元;其去年虧損收窄至6.08億元人民幣,上年同期蝕15.38億元人民幣。同業阿里健康(00241.HK)、京東健康(06618.HK)則隨大市跌2%至3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.